{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:05:50Z","timestamp":1790867150203,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2912,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.virol.2005.06.002","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T10:48:06Z","timestamp":1120301286000},"page":"164-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model"],"prefix":"10.1016","volume":"339","author":[{"given":"Clement A.","family":"Meseda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonzo D.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunima","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Merchlinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry P.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.virol.2005.06.002_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.virol.2005.06.002_bib2","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt 5","key":"10.1016\/j.virol.2005.06.002_bib3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.virol.2005.06.002_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/oxfordjournals.aje.a121360","article-title":"The nature of the immune state produced by inactivated vaccinia virus in rabbits","volume":"94","author":"Boulter","year":"1971","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.002_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2005.06.002_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2005.06.002_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"BioTechniques"},{"issue":"9","key":"10.1016\/j.virol.2005.06.002_bib8","first-page":"2330","article-title":"Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration","volume":"5","author":"Conry","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.virol.2005.06.002_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.06.002_bib10","first-page":"16.16.1","article-title":"Preparation of cell cultures and vaccinia virus stocks","volume":"vol. 3","author":"Earl","year":"1998"},{"issue":"6979","key":"10.1016\/j.virol.2005.06.002_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2005.06.002_bib12","series-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"issue":"19","key":"10.1016\/j.virol.2005.06.002_bib13","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.002_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2005.06.002_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1099\/0022-1317-40-2-345","article-title":"Photochemical inactivation of DNA and RNA viruses by psoralen derivatives","volume":"40","author":"Hanson","year":"1978","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.virol.2005.06.002_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3201\/eid0403.980340","article-title":"Bioterrorism as a public health threat","volume":"4","author":"Henderson","year":"1998","journal-title":"Emerg. Infect. Dis."},{"issue":"5406","key":"10.1016\/j.virol.2005.06.002_bib17","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.06.002_bib18","series-title":"Vaccines","first-page":"74","article-title":"Smallpox and vaccinia","author":"Henderson","year":"1999"},{"issue":"2","key":"10.1016\/j.virol.2005.06.002_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2005.06.002_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2005.06.002_bib21","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.06.002_bib22","series-title":"Diagnostic Procedures of Virus and Rickettsial Disease","first-page":"45","article-title":"General principles underlying laboratory diagnosis of virus and rickettsial infections","author":"Lennette","year":"1964"},{"issue":"1","key":"10.1016\/j.virol.2005.06.002_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2004.07.024","article-title":"Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement","volume":"328","author":"Lustig","year":"2004","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2005.06.002_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/376557","article-title":"Development of a novel vaccinia-neutralization assay based on reporter-gene expression","volume":"188","author":"Manischewitz","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2005.06.002_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5858\/2000-124-0362-AMMOAT","article-title":"A mouse model of aerosol-transmitted orthopoxviral disease: morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB\/c mouse system","volume":"124","author":"Martinez","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5\u20136","key":"10.1016\/j.virol.2005.06.002_bib26","first-page":"375","article-title":"[The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)]","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl. Bakteriol. [B]"},{"issue":"720","key":"10.1016\/j.virol.2005.06.002_bib27","first-page":"815","article-title":"Clinical applications of jet injection","volume":"95","author":"McKenzie","year":"1982","journal-title":"N. Z. Med. J."},{"issue":"8","key":"10.1016\/j.virol.2005.06.002_bib28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1086\/344234","article-title":"Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone","volume":"186","author":"Meseda","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2005.06.002_bib29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2005.06.002_bib30","first-page":"289","article-title":"Mouse models for studying orthopoxvirus respiratory infections","volume":"269","author":"Schriewer","year":"2004","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.virol.2005.06.002_bib31","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.73.2.1092-1098.1999","article-title":"Two-helper RNA system for production of recombinant Semliki forest virus particles","volume":"73","author":"Smerdou","year":"1999","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.virol.2005.06.002_bib32","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J. Virol."},{"issue":"47","key":"10.1016\/j.virol.2005.06.002_bib33","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1055\/s-0028-1108143","article-title":"MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)","volume":"99","author":"Stickl","year":"1974","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"Pt 10","key":"10.1016\/j.virol.2005.06.002_bib34","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1099\/0022-1317-80-10-2751","article-title":"A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae","volume":"80","author":"Tscharke","year":"1999","journal-title":"J. Gen. Virol."},{"issue":"Pt 8","key":"10.1016\/j.virol.2005.06.002_bib35","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1099\/0022-1317-83-8-1977","article-title":"Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes","volume":"83","author":"Tscharke","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.virol.2005.06.002_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1099\/0022-1317-1-3-399","article-title":"Respiratory infection of mice with vaccinia virus","volume":"1","author":"Turner","year":"1967","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.002_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1099\/0022-1317-13-1-19","article-title":"Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus","volume":"13","author":"Turner","year":"1971","journal-title":"J. Gen. Virol."},{"issue":"Pt 1","key":"10.1016\/j.virol.2005.06.002_bib38","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1099\/0022-1317-71-11-2761","article-title":"Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route","volume":"71","author":"Williamson","year":"1990","journal-title":"J. Gen. Virol."},{"issue":"13","key":"10.1016\/j.virol.2005.06.002_bib39","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205003260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205003260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:36:42Z","timestamp":1758584202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682205003260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0042682205003260"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.06.002","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}